AngelMed receives FDA approval for Guardian upgraded battery
Filed with ASX · · 3 pages · English
In the deck
Story so far
Earlier from Hydrix
- 2020 AGM - Executive Chairmans Presentation
- First in human trials of Phyzhon Health PHYRARI FFR-WIRE
- Phyzhon appoints Hydrix as exclusive distributor
- Hydrix raises $10m under institutional placement
- Trading Halt
Later from Hydrix
- Investor Presentation - AngelMed Guardian FDA Approval
- Hydrix completes TGA submission for AngelMed Guardian System
- AngelMed completes its first USA commercial Guardian implant
- Commercial arrangement between Hydrix and Memphasys
- FY2021 Letter from Executive Chairman
Follow Hydrix into a list and get an email when it puts out news.
Follow Hydrix